European Archives - Page 50 of 1131 - European Medical Journal

Maternal Exposure to Polychlorinated Biphenyls Not Linked to Allergic Diseases

This study aimed to assess whether maternal exposure to LC-PCBs in indoor air during pregnancy was associated with the development of asthma.

Rising Alcohol-Related Liver Disease in Women Worldwide

The “wine mum” culture, which normalises excessive alcohol consumption, further perpetuates harmful drinking behaviours.

Pharma must balance creativity and trust in 2025, says VML

Pharma must balance creativity with transparency to rebuild trust in 2025. VML Health’s report reveals key trends shaping expectations.

Mini Rolling Robot Pioneers Virtual Biopsies for Early Cancer Detection

An oloid-shaped robot has enabled the use of 3D virtual biopsies, showing potential to transform early cancer detection in the gut.

Biomarkers Forecast Interstitial Lung Disease in Rheumatoid Arthritis

KL-6 and hSP-D levels at baseline, and changes in KL-6 over time, are strongly associated with progression of RA-associated interstitial lung disease, according to a Korean prospective cohort study.

Study Finds Uterine Fibroid Diagnosis Rates Vary by Ethnicity

South Asian, East Asian, Southeast Asian, Black, and Hispanic patients were all more likely than White patients to be diagnosed with fibroids in a study of nearly 2 million individuals.

Capillary Lactate Predicts Sepsis Outcomes and Mortality

Capillary lactate levels strongly correlate with venous lactate and predict outcomes in patients with sepsis.

Matcha Beats Green Tea in Radiation Gut Protection

New research suggests matcha may offer greater protection than green tea against intestinal injury caused by gamma radiation, via the TAK1–TAB pathway.

Newer Biologics Reduce Infection Risk in Patients with Psoriasis

The study assessed the risk of hospitalisation for serious infections based on different categories of systemic medications.

S1P: Receptor Modulators in Ulcerative Colitis

S1P Receptor Modulators in Ulcerative Colitis: A Growing Track Record in the Moderate UC Patient’, a BMS promotional symposium that took place at the United European Gastroenterology (UEG) Week 2024. 𝗙𝗼𝗿 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗣𝗿𝗼𝗳𝗲𝘀𝘀𝗶𝗼𝗻𝗮𝗹𝘀 𝗼𝗻𝗹𝘆. 𝗧𝗵𝗶𝘀 𝘀𝘆𝗺𝗽𝗼𝘀𝗶𝘂𝗺 𝘄𝗮𝘀 𝗼𝗿𝗴𝗮𝗻𝗶𝘀𝗲𝗱 𝗮𝗻𝗱 𝗳𝘂𝗻𝗱𝗲𝗱 𝗯𝘆 𝗕𝗿𝗶𝘀𝘁𝗼𝗹 𝗠𝘆𝗲𝗿𝘀 𝗦𝗾𝘂𝗶𝗯𝗯. 𝗕𝗠𝗦 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀 𝗮𝗻𝗱/𝗼𝗿 𝗽𝗿𝗼𝗱𝘂𝗰𝘁 𝗶𝗻𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 𝗺𝗮𝘆 𝗯𝗲 𝗱𝗶𝘀𝗰𝘂𝘀𝘀𝗲𝗱. 𝗜𝗠𝗠-𝗚𝗕-𝟮𝟰𝟬𝟬𝟯𝟬𝟯 | 𝗗𝗮𝘁𝗲 𝗼𝗳 𝗣𝗿𝗲𝗽: 𝗔𝗽𝗿𝗶𝗹 𝟮𝟬𝟮𝟱